REPLICor is developing its drug as a broad spectrum antiviral that could generate an important impact in the medical field. This drug is the first broad-spectrum antiviral compound ever described having activity in at least 12 families of viruses.
|
Hepatitis Viruses |
Activity |
Activity |
|
in vitro |
in vivo |
|
|
Hepatitis B (HBV) |
Yes |
Yes |
|
Duck HBV |
Yes |
Yes |
|
Hepatitis C (HCV) |
Yes |
Yes |
|
|
|
|
|
Respiratory Viruses |
Activity |
Activity |
|
in vitro |
in vivo |
|
|
Influenza A |
Yes |
Yes |
|
Influenza B |
Yes |
|
|
Respiratory syncytial (RSV) |
Yes |
Yes |
|
Human metapneumovirus |
Yes |
|
|
|
|
|
|
Herpes Viruses |
Activity |
Activity |
|
in vitro |
in vivo |
|
|
Herpes simplex 1 (HSV-1) |
Yes |
|
|
Herpes simplex 2 (HSV-2) |
Yes |
Yes |
|
Cytomegalovirus (CMV) |
Yes |
Yes |
|
Varicella zoster (VZV) |
Yes |
|
|
Epstein-Barr (EBV) |
Yes |
|
|
Human herpes HHV-6A and 6B |
Yes |
|
|
|
|
|
|
Immunodeficiency Viruses |
Activity |
Activity |
|
in vitro |
in vivo |
|
|
HIV-1 |
Yes |
|
|
Friend leukemia |
|
Yes |
|
|
|
|
|
Biodefense Viruses |
Activity |
Activity |
|
in vitro |
in vivo |
|
|
Ebola |
Yes |
Yes |
|
Marburg |
Yes |
|
|
Lassa fever |
Yes |
Yes |
|
Vaccinia (smallpox surrogate) |
Yes |
Yes |
|
Mousepox (ectromelia) |
Yes |
|
|
|
|
|
|
Emerging & Tropical Viruses |
Activity |
Activity |
|
|
in vitro |
in vivo |
|
Hantavirus |
Yes |
|
|
Hantaan |
Yes |
|
|
Crimean Congo Hem. fever |
Yes |
|
|
Rift Valley Fever |
Yes |
|
|
West Nile |
Yes |
|
|
Yellow fever |
Yes |
|
|
Dengue |
Yes |
|
|
Tick born encephalitis |
Yes |
|
|
Western equine encephalitis |
Yes |
|
|
Venezuelan equine encephalitis |
Yes |
|